Invivyd (IVVD) is an interesting biotech because it has already received emergency use authorization [EUA] from the FDA for its pre-exposure prophylaxis [PrEP] vaccine candidate PEMGARDA [pemivibart] ...
Viral vectors and vaccines navigate public distrust while advancing through AI design, COVID response lessons, and promising ...
High-titre convalescent plasma therapy given within a week of symptom onset reduced hospitalisation and death and was well tolerated in immunocompromised patients with mild COVID-19. This randomised ...
NEWTOWN, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (TRAW) (“Traws Pharma”, “Traws” or “the Company”), a clinical-stage biopharmaceutical company developing novel therapies to target ...
Shionogi & Co. Ltd. won a $375 million project agreement from the Rapid Response Partnership Vehicle to develop its 3CL protease inhibitor, S-892216, as a long-acting injectable for COVID-19 ...
Nov 23 (Reuters) - Merck & Co Inc (MRK.N), opens new tab has agreed to acquire drugmaker OncoImmune in a deal that will give it control of a drug that could help ease symptoms and reduce deaths in ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. ST. LOUIS- The Missouri Education Senate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results